ODULIMOMAB

UNII: 39R9XU694M
Preferred Substance Name: ODULIMOMAB

159445-64-4
ANTI-LFA1
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD11 (ANTIGEN) .ALPHA.-CHAIN) (MOUSE MONOCLONAL 25.3 .GAMMA.1-CHAIN), DISULFIDE WITH MOUSE MONOCLONAL 25.3 LIGHT CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD11 (ANTIGEN) A-CHAIN) (MOUSE MONOCLONAL 25.3 G1-CHAIN), DISULFIDE WITH MOUSE MONOCLONAL 25.3 LIGHT CHAIN, DIMER
ODULIMOMAB [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

ODULIMOMAB

Synonyms and Mappings

Resources

Note